重定向E3无素连接酶用于具有异质识别域的向蛋白质降解
Huan Yang1, Ge Zheng1, Grace Y Li2
1Department of Pediatrics, Dana Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
The Journal of biological chemistry
|December 15, 2024
概括
研究人员探索了TRIM10和TRIM58 E3连接酶对BCL11A的向蛋白质降解. 这一策略使红色素细胞的选择性蛋白质耗尽成为可能,为血红蛋白病变提供了新的治疗途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质降解 (TPD) 是一个有前途的治疗策略,利用蛋白质分解向仿真体或分子.
- 目前,只有少数E3链酶,如cereblon和von Hippel-Lindau瘤抑制剂 (VHL),在TPD中得到广泛使用.
- 扩大对TPD的E3结合酶的谱系对于开发向疗法至关重要.
研究的目的:
- 为了研究红状腺细胞丰富的E3化酶TRIM10和TRIM58对向蛋白质降解的潜力.
- 用TRIM10和TRIM58.8来评估BCL11A的降解,BCL11A是β-hemoglobinopathies的治疗点,使用TRIM10和TRIM58.
- 为在TPD中使用新型E3结合酶建立一个可通用的策略.
主要方法:
- 通过将它们的 PRY-SPRY 域替换为异质识别域来设计 TRIM10 和 TRIM58.
- 利用卷轴,纳米体和大脑基质识别域来招募TRIM10或TRIM58到BCL11A.
- 评估了由工程E3酶介导的BCL11A的降解.
主要成果:
- 如果成功地将TRIM10或TRIM58引入BCL11A,则会导致其降解.
- 证明了使用工程TRIM10和TRIM58用于向蛋白质耗尽的可行性.
- 验证了一种新的策略来评估E3链酶的TPD潜力.
结论:
- TRIM10和TRIM58可用于在红状腺细胞中准BCL11A的蛋白质降解.
- 开发的战略为探索用于TPD应用的其他E3结合酶提供了一个框架.
- 这项研究支持TRIM10和TRIM58的配体的开发,用于红状腺选择性蛋白质耗尽疗法.
相关概念视频
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
813
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
813
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K


